Clinical Trial Update: Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus bevacizumab and an anti-PD-1 antibody, followed by induction therapy with chemotherapy plus bevacizumab, for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anti-PD-1 antibody
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Zhangfa Song | Conditions: Metastatic Colorectal Cancer, MSS | Phase 2 | Status: NOT_YET_RECRUITING